Last reviewed · How we verify
NCT05813769: DaPa
Dairy and Plant Amino Acid Uptake. An Explorative Study
NA trial testing Dairy protein in Amino Acid Plasma Profile in 12 participants. Completed in 21 June 2023.
21 June 2023
Quick facts
| Lead sponsor | FrieslandCampina |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 12 |
| Start date | 9 May 2023 |
| Primary completion | 21 June 2023 |
| Estimated completion | 21 June 2023 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Dairy protein
- Plant protein
Conditions studied
- Amino Acid Plasma Profile — all drugs for Amino Acid Plasma Profile →
Sponsor
FrieslandCampina — full company profile →
Who can join
Adults 18 to 40, any sex, with Amino Acid Plasma Profile. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To optimize the environmental sustainability, a protein transition to more plant-based protein sources is required. However, the protein quality of plant-based sources is lower than that of the dairy proteins casein and whey, which contain high levels of essential amino acids. The amino acid absorption characteristics of many plant-based proteins are unknown. The present study aims to estimate differences in postprandial plasma total essential amino acids (TEAA) profiles after protein consumption of different protein sources in blood of healthy participants. This explorative study has a randomized, cross-over, double-blind, controlled design.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05813769
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dairy protein
Trials testing the same drug.
- NCT03557463 — Testing a Novel Dairy Protein to Counteract Immunosenescence · NA · completed
Other FrieslandCampina trials
Trials by the same sponsor.
- NCT07242508 — Efficacy of a New Infant Formula Composition on Gut Health in Infants · NA · not yet recruiting
- NCT06251427 — Assessing the Effectiveness of a Multiple-micronutrient Fortified Maize Pap on the Nutrient Status of Nigerian School-ag · NA · completed
- NCT05670002 — Nutrition Intervention of Complementary Milk Feeding to Improve Linear Growth of at Risk and Stunted Children · NA · completed
- NCT05418491 — The Prolonged Effect of Consumption of a Partially Hydrolyzed Infant Formula During the First 6 Months of Life on the De · completed
- NCT05372601 — Prebiotics and Stress Reduction in Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05813769 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FrieslandCampina
- Last refreshed: 26 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05813769.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing